Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and inter...
Deepening in the Chinese technology sector, the latest holdings of foreign public funds have been released
LBPMedicin: Loss of 12.4985 million yuan in the first half of the year
LBPMedicin: Nanjing Qianjing plans to reduce its holdings by no more than 1.79% of its shares
LBPMedicin's multiple products have obtained EU CE certification
LBPMedicin obtained a medical device registration certificate
Major AI medical policies released, 19 stocks worth paying attention to